Bard Associates Inc. Has $1.24 Million Holdings in Utah Medical Products, Inc. (NASDAQ:UTMD)

Bard Associates Inc. raised its holdings in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 1.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 20,030 shares of the medical instruments supplier’s stock after purchasing an additional 249 shares during the period. Bard Associates Inc.’s holdings in Utah Medical Products were worth $1,237,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in UTMD. Golden State Wealth Management LLC acquired a new position in Utah Medical Products during the 4th quarter valued at about $31,000. R Squared Ltd bought a new stake in shares of Utah Medical Products in the 4th quarter valued at about $49,000. BNP Paribas Financial Markets increased its stake in shares of Utah Medical Products by 102.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock valued at $75,000 after acquiring an additional 566 shares during the last quarter. SG Americas Securities LLC bought a new stake in shares of Utah Medical Products in the 4th quarter valued at about $157,000. Finally, Virtu Financial LLC bought a new stake in shares of Utah Medical Products in the 3rd quarter valued at about $207,000. 69.60% of the stock is currently owned by institutional investors and hedge funds.

Utah Medical Products Price Performance

Shares of UTMD stock opened at $59.23 on Tuesday. The stock has a market cap of $200.91 million, a PE ratio of 14.99 and a beta of 0.08. The stock has a 50-day moving average of $61.16 and a 200-day moving average of $64.11. Utah Medical Products, Inc. has a one year low of $58.87 and a one year high of $77.33.

Utah Medical Products (NASDAQ:UTMD) last announced its quarterly earnings results on Tuesday, January 28th. The medical instruments supplier reported $0.86 EPS for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%.

Utah Medical Products Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 3rd. Shareholders of record on Friday, March 14th will be paid a $0.305 dividend. This represents a $1.22 dividend on an annualized basis and a yield of 2.06%. The ex-dividend date of this dividend is Friday, March 14th. Utah Medical Products’s payout ratio is currently 30.89%.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 7th.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.